Erythropoietin Resistance in Patients with Chronic Kidney Disease: Current Perspectives

Anemia is a frequent complication of chronic kidney disease, and its primary cause is erythropoietin deficiency. After diagnosis, treatment begins with administration of an erythropoiesis-stimulating agent (ESA). However, some patients present with resistance to ESA, which needs to be reversed, as i...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Elton Jonh Freitas, Dias, Raimunda Sheyla Carneiro, Lima, Janielle Ferreira de Brito, Salgado Filho, Natalino, Miranda dos Santos, Alcione
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549651/
https://www.ncbi.nlm.nih.gov/pubmed/33116754
http://dx.doi.org/10.2147/IJNRD.S239151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549651/
https://www.ncbi.nlm.nih.gov/pubmed/33116754
http://dx.doi.org/10.2147/IJNRD.S239151

Ejemplares similares